EDITORIAL: Intraperitoneal Chemotherapy Comes of Age
4th Jan 2006, 23:56 GMT
Patients with advanced epithelial ovarian cancer typically receive intravenous taxane and platinum-based chemotherapy in an attempt to eradicate residual disease after surgical debulking. This treatment yields overall median survivals of ...
EDITORIAL: Intraperitoneal Chemotherapy Comes of Age related news:
- Intraperitoneal chemotherapy administration prolongs survival for women with advanced ovarian cancer — EurekAlert! - Breaking News
- ORIGINAL ARTICLE: Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer — New England Journal of Medicine -- Recent Issues
- New Chemotherapy Regimen Improves Survival for Advanced Ovarian Cancer Patients — Blogcritics
- Ovarian cancer responds to abdominal chemotherapy — U.S. News & World Report
- (ATTN: Editorial Page editors) — Daily Herald (Opinion)
- Underutilized treatment for advanced ovarian cancer found to significantly improve survival — EurekAlert! - Breaking News
- Old Method For Delivering Chemotherapy Directly Into Abdomen Making A Comeback — Medical News Today RSS/XML Feed
- Delivering chemotherapy directly into the abdomen boosts survival in ovarian cancer patients — News-Medical News Feed
- MEDICAID: Harder times in Theodosia — STLtoday.com Top Editorial Headlines
- THE SAGO DISASTER: Collateral damage — STLtoday.com Top Editorial Headlines
Latest news from New England Journal of Medicine -- Recent Issues:
- EARLY RELEASE: Reducing the Door-to-Balloon Time for Myocardial Infarction with ST-Segment Elevation
- EARLY RELEASE: Strategies for Reducing the Door-to-Balloon Time in Acute Myocardial Infarction
- EARLY RELEASE: Myocardial Infarction and the Open-Artery Hypothesis
- EARLY RELEASE: Coronary Intervention for Persistent Occlusion after Myocardial Infarction
- PERSPECTIVE: Recalibrating Medicare Payments for Inpatient Care
- PERSPECTIVE: Violence and Mental Illness -- How Strong is the Link?
- PERSPECTIVE: Murder or Mercy? Hurricane Katrina and the Need for Disaster Training
- ORIGINAL ARTICLE: Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
- ORIGINAL ARTICLE: Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
- ORIGINAL ARTICLE: Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia